180 related articles for article (PubMed ID: 30043709)
1. Moleculer dynamics simulaiton revealed reciever domain of
Ahmad S; Shaker B; Ahmad F; Raza S; Azam SS
J Biomol Struct Dyn; 2019 Jul; 37(11):2897-2912. PubMed ID: 30043709
[No Abstract] [Full Text] [Related]
2. Unveiling MurE ligase potential inhibitors for treating multi-drug resistant
Altharawi A; Alqahatani SM; Alanazi MM; Tahir Ul Qamar M
J Biomol Struct Dyn; 2024 Mar; 42(5):2358-2368. PubMed ID: 37099644
[No Abstract] [Full Text] [Related]
3. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
4. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560
[TBL] [Abstract][Full Text] [Related]
5. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
[TBL] [Abstract][Full Text] [Related]
6. High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of
Lokhande KB; Pawar SV; Madkaiker S; Nawani N; Venkateswara SK; Ghosh P
J Biomol Struct Dyn; 2023 Apr; 41(7):2698-2712. PubMed ID: 35156902
[No Abstract] [Full Text] [Related]
7. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
[TBL] [Abstract][Full Text] [Related]
8. Toward novel inhibitors against KdsB: a highly specific and selective broad-spectrum bacterial enzyme.
Ahmad S; Raza S; Abro A; Liedl KR; Azam SS
J Biomol Struct Dyn; 2019 Mar; 37(5):1326-1345. PubMed ID: 29606084
[TBL] [Abstract][Full Text] [Related]
9. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.
Verma P; Tiwari M; Tiwari V
J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677
[TBL] [Abstract][Full Text] [Related]
10. Structure Based in Silico Screening Revealed a Potent Acinetobacter Baumannii Ftsz Inhibitor From Asinex Antibacterial Library.
Navid A; Ahmad S; Sajjad R; Raza S; Azam SS
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):3008-3018. PubMed ID: 34375286
[TBL] [Abstract][Full Text] [Related]
11. Structure prediction and discovery of inhibitors against phosphopantothenoyl cysteine synthetase of
Gupta A; Vijayan V; Pant P; Kaur P; Singh TP; Sharma P; Sharma S
J Biomol Struct Dyn; 2022; 40(21):11405-11417. PubMed ID: 34348086
[No Abstract] [Full Text] [Related]
12. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays.
Skariyachan S; Manjunath M; Bachappanavar N
J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934
[TBL] [Abstract][Full Text] [Related]
13. Binding mode analysis, dynamic simulation and binding free energy calculations of the MurF ligase from Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2017 Oct; 77():72-85. PubMed ID: 28843462
[TBL] [Abstract][Full Text] [Related]
14. The Structure of the Biofilm-controlling Response Regulator BfmR from Acinetobacter baumannii Reveals Details of Its DNA-binding Mechanism.
Draughn GL; Milton ME; Feldmann EA; Bobay BG; Roth BM; Olson AL; Thompson RJ; Actis LA; Davies C; Cavanagh J
J Mol Biol; 2018 Mar; 430(6):806-821. PubMed ID: 29438671
[TBL] [Abstract][Full Text] [Related]
15. Computational screening and MM/GBSA-based MD simulation studies reveal the high binding potential of FDA-approved drugs against
Singh AP; Ahmad S; Raza K; Gautam HK
J Biomol Struct Dyn; 2024 Aug; 42(12):6245-6255. PubMed ID: 37545341
[No Abstract] [Full Text] [Related]
16. Identification of novel natural MurD ligase inhibitors as potential antimicrobial agents targeting
Tiwari P; Sharma P; Kumar M; Kapil A; Abdul Samath E; Kaur P
J Biomol Struct Dyn; 2022; 40(24):14051-14066. PubMed ID: 34766874
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling studies to explore the binding affinity of virtually screened inhibitor toward different aminoglycoside kinases from diverse MDR strains.
Parulekar RS; Sonawane KD
J Cell Biochem; 2018 Mar; 119(3):2679-2695. PubMed ID: 29057497
[TBL] [Abstract][Full Text] [Related]
18. Cyanobacterial compound Tolyporphine K as an inhibitor of Apo-PBP (penicillin-binding protein) in
Gurnani M; Chauhan A; Ranjan A; Gopi P; Ghosh A; Tuli HS; Haque S; Pandya P; Lal R; Jindal T
J Biomol Struct Dyn; 2024 May; 42(8):4133-4144. PubMed ID: 37261797
[TBL] [Abstract][Full Text] [Related]
19. Targeting Outer Membrane Protein Component AdeC for the Discovery of Efflux Pump Inhibitor against AdeABC Efflux Pump of Multidrug Resistant Acinetobacter baumannii.
Verma P; Tiwari V
Cell Biochem Biophys; 2018 Sep; 76(3):391-400. PubMed ID: 29926429
[TBL] [Abstract][Full Text] [Related]
20. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
